Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Episode 188 of the Answers from the Lab podcast, hosted by Mayo Clinic Laboratories, titled "Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S." was published on November 8, 2022 and runs 8 minutes.
November 8, 2022 ·8m · Answers from the Lab
Summary
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Episode Description
(00:31)
Can you please provide us a little bit of background about yourself?
(01:29)
Can you give us an overview of this assay?
(02:44)
Can you talk about what genes have been added, and why?
(04:16)
Can you talk about patients who should have this testing?
(06:20)
Are there any last comments that you would like to make about the new gastrointestinal tumor panel?
Similar Episodes
Apr 5, 2026 ·6m
Apr 2, 2026 ·5m
Mar 29, 2026 ·7m
Mar 19, 2026 ·5m
Mar 15, 2026 ·7m
Mar 9, 2026 ·12m